Consistent with that, using an induced overexpressing DSP model of non-small cell lung cancer (NSCLC), the tumour-suppressive function of DSP behaviour was demonstrated through the inhibition of the Wnt/β-catenin/TCF/LEF (transcription factor) pathway [51]. Here, DSP is linked to non-small cell lung carcinoma.